Form 4: Imunon Inc. Insider Trades: Chief Medical Officer Acquires Stock
Statement of Changes in Beneficial Ownership
Imunon, Inc. reports that Chief Medical Officer Douglas Vincent Faller acquired 1,308 shares of common stock on July 2, 2026, valued at $1.91 per share, as part of a stock grant in lieu of cash for a portion of his base salary.
Summary
- Douglas Vincent Faller, Chief Medical Officer of Imunon, Inc., acquired 1,308 shares of common stock on July 2, 2026.
- The acquisition was made at a price of $1.91 per share.
- These shares were granted in lieu of cash for a portion of Mr. Faller's base salary.
- Following this transaction, Mr. Faller beneficially owns 23,204 shares of common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard compensation-related stock grant to an executive rather than a discretionary purchase or sale that might indicate stronger sentiment.
Positives
- Insider acquisition of stock can signal confidence in the company's future prospects.
- The Chief Medical Officer is increasing their direct beneficial ownership in the company.
Future Outlook
No specific forward-looking statements or guidance are provided in this Form 4 filing.
Industry Context
StockSavvy.ai notes that insider stock acquisitions, particularly when tied to compensation, are common within the biotechnology and pharmaceutical sectors as companies seek to align executive interests with shareholder value, especially during periods of development or early-stage commercialization.
Stakeholder Impact
- Shareholders: The acquisition by an executive may be viewed positively as a sign of commitment, but the nature of the transaction (in lieu of salary) means it does not represent new capital investment.
- Employees: This transaction relates to executive compensation and does not directly impact other employees.
- Management: The Chief Medical Officer is compensated partly through stock, aligning their interests with the company.
Key Dates
| Date | Description |
|---|---|
| 07/02/2026 | Transaction date for stock acquisition by Douglas Vincent Faller. |
| 07/07/2026 | Date of signature for the filing. |
Keywords
Imunon Inc., IMNN, Form 4, Insider Trading, Stock Acquisition, Chief Medical Officer, Beneficial Ownership, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.